Heart involvement in systemic sclerosis: An ultrasonic tissue characterisation study

Annals of the Rheumatic Diseases

Volumn 57, Issue 5, 1998, Pages 296-302

  Ferri, Clodoveo ^a,c   Di Bello, Vitantonio ^a   Martini, Antonella ^a   Giorgi, Davide ^a   Storino, Franca A A ^a   Bianchi, Massimiliano ^a   Bertini, Alessio ^a   Paterni, Marco ^b   Giusti, Costantino ^a   Pasero, Giampiero ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c Department of Internal Medicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART RHYTHM; HUMAN; MALE; MICROCIRCULATION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; SYSTOLE; VIDEODENSITOMETRY;

EID: 7344257186     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.5.296     Document Type: Article

References (46)

1. Medsger TA Jr. Systemic sclerosis (scleroderma), localized scleroderma, eosiniphilic fascitis, and calcinosis. In: McCarty DJ, ed. Arthritis and allied conditions. Philadelphia: Lea and Febiger, 1118-65.
2. Deswal A, Follansbee WP. Cardiac involvement in scleroderma. Rheum Dis Clin North Am 1996;22:841-61.
3. Clements PI, Furst DE, Cabeen W, Tashkin D, Paulus HE, Roberts N. The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS). Am J Med 1981;71:38-46.
4. Ferri C, Bernini L, Bongiorni MG, Levorato D, Viegi G, Bravi P, et al. Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients. Arthritis Rheum 1985;28:1259-66.
5. Ferri C, Bernini L, Cecchetti R, Latorraca A, Marotta G, Passero G, et al. Cutaneous and serological subsets of systemic sclerosis. J Rheumatol 1991;18:1826-32.
6. Steen VD, Powell DL, Medsger TA. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
7. Roberts NK, Cabeen WR, Moss J, Clements PJ, Furst DE. The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. Ann Intern Med 1981;94:38-40.
8. James TN. De subitaneis mortibus: VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974;50:844-56.
9. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls Am J Med 1969;46:428-40.
10. Follansbee WP, Miller TR, Curtiss EI, Orie JE, Bernstein RL, Kiernan JM, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990;17:656-62.
11. McWhorter JE IV, LeRoy EC. Pericardial disease in scleroderma (systemic sclerosis). Am J Med 1974;57:566-71.
12. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: A cause of cardiac dysfunction. Circulation 1976;53:483-90.
13. Follansbee WP, Curtiss EI, Medsger TA, Steen VD, Uretsky BF, Owens GR, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984;310:142-8.
14. Alexander EL, Firestein GS, Weiss JL, Heuser RR, Leitl G, Wagner HN Jr, et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986;105:661-72.
15. Kahan A, Nitenberg A, Foult JM, Amor B, Menkes CJ, Devaux JY, et al. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 1985;28: 637-46.
16. Kahan A, Devaux J, Amor B, Menkes CJ, Weber S, Nitenberg A, et al. Nifedipine and Thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986;314:1397-402.
17. Steen VD, Follansbee WP. Thallium perfusion abnormalities predict survival and cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum 1992;35:S37.
18. Skorton DJ, Collins SM, Nichols J, Pandian NG, Bean JA, Kerber RE. Quantitative texture analysis in two-dimensional echocardiography: application to the diagnosis of experimental myocardial contusion. Circulation 1983; 68:217-23.
19. Skorton DJ, Melton HE, Pandian NG, Nichols J, Koyanagi S, Marcus ML, et al. Detection of acute myocardial infarction in closed-chest dog by analysis of regional two-dimensional echocardiographic gray-level distributions. Circ Res 1983;52:36-44.
20. Pinamonti B, Picano E, Ferdeghini EM, Lattanzi F, Slavich G, Landini L, et al. Quantitative texture analysis in two-dimensional echocardiography: application to the diagnosis of myocardial amyloidosis. J Am Coll Cardiol 1989;14:666-71.
21. Chandrasekaran K, Aylward PE, Bsee SRF, Burns TL, Seward JB, Tajik AJ, et al. Feasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerised quantitative texture analysis of clinical echocardiographic data. J Am Coll Cardiol 1989;13:832-40.
22. Lieback E, Hardouin I, Meyer R, Bellach J, Hetzer H. Clinical value of echocardiographic tissue characterisation in the diagnosis of myocarditis. Eur Heart J 1996;17:135-42.
23. Picano E, Faletra F, Marini C, Paterni M, Danzi GB, Lombardi M, et al. Increased echodensity of transiently asynergic myocardium in humans: a novel echocardiographic sign of myocardial ischemia. J Am Coll Cardiol 1993;21:199-207.
24. Di Bello V, Pedrinelli R, Giorgi D, Bertini A, Talarico L, Caputo MT, et al. Ultrasonic videodensitometric analysis of two different models of left ventricular hypertrophy: athlete's heart and hypertension. Hypertension 1997;29:937-44.
25. Di Bello V, Giampietro O, Matteucci E, Talarico L, Giorgi D, Bertini A, et al. Ultrasonic videodensitometric analysis in type I diabetic myocardium. Coronary artery disease 1996;7:895-901.
26. Masi AT, Rodnan GP, Medsger TA Jr, Altman RD, D'Angelo, WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
27. Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986;4:367-69.
28. Maricq HR. Widefield capillary microscopy: tecnique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981;24:1159-65.
29. Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM. Autoantibody to centromere (chinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980;77:1627-31.
30. Bunn CC, Gharavi AE, Hughes GRV. Antibodies to extractable nuclear antigens in 173 patients with DNA binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigen observed by counterimmunoelectrophoresis. J Clin Lab Immunol 1982;8:13-17.
31. Venables PJV, Smith PR, Maini RN. Purification and characterization of the Sjögren's syndrome A and B antigens. Clin Exp Immunol 1983;54:731-8.
32. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
33. Devereux RB, Lutas ME, Casale PN, Kligfield P. Eisemberg RR, Hammond IW, et al. Standardization of M-Mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984;4:1222-30.
34. Lythall DA, Gibson DG, Kushwaha S, Norell MS, Mitchell AG, Ilsley CJD. Changes in myocardial echo amplitude during reversible ischemia in humans. Br Heart J 1992;67: 368-76.
35. Wind BE, Snider AR, Buda AJ, O'Neill WW, Topol EJ, Dilworth LR. Pulsed Doppler assessment of left ventricular diastolic filling in coronary artery disease before and immediately after coronary angioplasty. Am J Cardiol 1987;59:1041-6.
36. Bryg RJ, Williams GA, Labovitz, AJ. Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 1987;59:971-5.
37. Smith VE, Zile MR. Relaxation and diastolic properties of the heart. In: Fozzard HA, et al, eds. The heart and cardiovascular system. 2nd ed. New York: Raven Press, 1991: 1353-67.
38. Marshall SA, Levine RA, Weyman AE. Echocardiography in cardiac research. In: Fozzard HA, et al, eds. The heart and cardiovascular system. 2nd ed. New York: Raven Press, 1991:745-838.
39. Miller JG, Perez JE, Sobel BE. Ultrasonic characterisation of myocardium. Prog Cardiovasc Dis 1985;28:85-110.
40. Skorton DJ, Miller JG, Wickline A, Barzilai B, Collins SM, Perez JE. Ultrasonic characterisation of cardiovascular tissue. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL, eds. Cardiac imaging. Philadelphia: WB Saunders, 1991:886-95.
41. Perez JE, Barzilai B, Wickline SA, Vered Z, Sobel BE, Miller JG. Quantitative characterization of myocardium with ultrasonic imaging. J Nucl Med Allied Sci 1988;32:149-57.
42. Angermann CE, Stempfle HU. Tissue characterization in myocardial disease. In: Roelantd JRTC, Sutherland GR, Iliceto S, Linker D, eds. Cardiac ultrasound. London: Churchill Livingstone, 1992:419.
43. Wickline SA, Thomas III LJ, Miller JG, Sobel BE, Perez JE. A relationship between ultrasonic integrated backscatter and myocardial contractile function. J Clin Invest 1985;76: 2151-60.
44. Logan-Sinclair R, Wong CM, Gibson DG. Clinical application of amplitude rocessing of echocardiographic images. Br Heart J 1981;45:621-7.
45. Bulkley BH, Klacsmann PG, Hutchins GM. Angina pectoris, myocardial infarction, and sudden cardiac death with normal coronary arteries: A clinicopathologic study of nine patients with progressive systemic sclerosis. Am Heart J 1978;95:563-74.
46. Ferri C, Emdin M, Giuggioli D, et al. Autonomic disfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol 1997;36:669-76.